Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fu Xu

Showing results (661-670 of 672) with videos related to

Pageof 68
Sort By:
Current Medical Science|March 21, 2023
Correlation between the Human Development Index and the Incidence and Mortality of Non-Hodgkin LymphomaWen-Fu Xu, Ping Yang, Zhi-Wen Wei, et al.
Frontiers in Public Health|May 30, 2023
Risk factors associated with indoor transmission during home quarantine of COVID-19 patientsYang Liu, Yan-Hua Chai, Yi-Fan Wu, et al.
American Journal of Respiratory and Critical Care Medicine|June 25, 2026
The frequent exacerbator phenotype in bronchiectasis revisited: Data from EMBARC registryOriol Sibila, Lidia Perea, Pierre Regis Burgel, et al.
Signal Transduction and Targeted Therapy|June 13, 2022
RING finger 138 deregulation distorts NF-кB signaling and facilities colitis switch to aggressive malignancyYalan Lu, Rong Huang, Jianming Ying, et al.
Blood|August 1, 2025
Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cellsCornelius Pauli, Michael Kienhöfer, Maximilian Felix Blank, et al.
Respiratory Research|December 3, 2022
The Establishment of China Bronchiectasis Registry and Research Collaboration (BE-China): Protocol of a prospective multicenter observational studyYong-Hua Gao, Hai-Wen Lu, Bei Mao, et al.
American Journal of Respiratory and Critical Care Medicine|January 17, 2012
Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activationJin-Fu Xu, George R Washko, Kiichi Nakahira, et al.
ERJ Open Research|February 27, 2024
A phase 4 multicentre, 2×2 factorial randomised, double-blind, placebo-controlled trial to investigate the efficacy and safety of tobramycin inhalation solution for <i>Pseudomonas aeruginosa</i> eradication in bronchiectasis: ERASEYong-Hua Gao, Hai-Wen Lu, Hui-Zhen Zheng, et al.
The Lancet. Respiratory Medicine|January 13, 2025
Baseline characteristics of patients in the Chinese Bronchiectasis Registry (BE-China): a multicentre prospective cohort studyJin-Fu Xu, Hui-Zhen Zheng, Hai-Wen Lu, et al.
The Lancet. Digital Health|June 6, 2020
Assessing risk factors for SARS-CoV-2 infection in patients presenting with symptoms in Shanghai, China: a multicentre, observational cohort studyBei Mao, Yang Liu, Yan-Hua Chai, et al.
Pageof 68

Showing results (661-670 of 672) with videos related to

Sort By:
Pageof 68
Current Medical Science|March 21, 2023
Correlation between the Human Development Index and the Incidence and Mortality of Non-Hodgkin LymphomaWen-Fu Xu, Ping Yang, Zhi-Wen Wei, et al.
Frontiers in Public Health|May 30, 2023
Risk factors associated with indoor transmission during home quarantine of COVID-19 patientsYang Liu, Yan-Hua Chai, Yi-Fan Wu, et al.
American Journal of Respiratory and Critical Care Medicine|June 25, 2026
The frequent exacerbator phenotype in bronchiectasis revisited: Data from EMBARC registryOriol Sibila, Lidia Perea, Pierre Regis Burgel, et al.
Signal Transduction and Targeted Therapy|June 13, 2022
RING finger 138 deregulation distorts NF-кB signaling and facilities colitis switch to aggressive malignancyYalan Lu, Rong Huang, Jianming Ying, et al.
Blood|August 1, 2025
Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cellsCornelius Pauli, Michael Kienhöfer, Maximilian Felix Blank, et al.
Respiratory Research|December 3, 2022
The Establishment of China Bronchiectasis Registry and Research Collaboration (BE-China): Protocol of a prospective multicenter observational studyYong-Hua Gao, Hai-Wen Lu, Bei Mao, et al.
American Journal of Respiratory and Critical Care Medicine|January 17, 2012
Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activationJin-Fu Xu, George R Washko, Kiichi Nakahira, et al.
ERJ Open Research|February 27, 2024
A phase 4 multicentre, 2×2 factorial randomised, double-blind, placebo-controlled trial to investigate the efficacy and safety of tobramycin inhalation solution for <i>Pseudomonas aeruginosa</i> eradication in bronchiectasis: ERASEYong-Hua Gao, Hai-Wen Lu, Hui-Zhen Zheng, et al.
The Lancet. Respiratory Medicine|January 13, 2025
Baseline characteristics of patients in the Chinese Bronchiectasis Registry (BE-China): a multicentre prospective cohort studyJin-Fu Xu, Hui-Zhen Zheng, Hai-Wen Lu, et al.
The Lancet. Digital Health|June 6, 2020
Assessing risk factors for SARS-CoV-2 infection in patients presenting with symptoms in Shanghai, China: a multicentre, observational cohort studyBei Mao, Yang Liu, Yan-Hua Chai, et al.
Pageof 68